Dana Haddad
- Genetics top 10%
- Oncology
- Biotechnology top 5%
- Molecular Biology
- Epidemiology
- Co-authors
- Yuman FongAladar A. SzalayJoshua CarsonNanhai G. ChenJoyce T. AuPat ZanzonicoQian ZhangChun‐Hao Chen
- Topics
- Virus-based gene therapy research (16 papers)Cancer Research and Treatments (11 papers)CAR-T cell therapy research (11 papers)
- Cited by
- BiotechnologyGeneticsOncology
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Dana Haddad
28 papers receiving 477 citations
Peers
Comparison fields: 5 of 52
- Genetics 319
- Oncology 217
- Biotechnology 158
- Molecular Biology 136
- Epidemiology 65
Countries citing papers authored by Dana Haddad
This map shows the geographic impact of Dana Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Haddad more than expected).
Fields of papers citing papers by Dana Haddad
This network shows the impact of papers produced by Dana Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Haddad. The network helps show where Dana Haddad may publish in the future.
Co-authorship network of co-authors of Dana Haddad
This figure shows the co-authorship network connecting the top 25 collaborators of Dana Haddad. A scholar is included among the top collaborators of Dana Haddad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Haddad. Dana Haddad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 10 | |
| 3 | 12 | |
| 4 | 13 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 9 | |
| 9 | 13 | |
| 10 | 16 | |
| 11 | 1 | |
| 12 | 17 | |
| 13 | 28 | |
| 14 | 21 | |
| 15 | 7 | |
| 16 | 33 | |
| 17 | 41 | |
| 18 | 6 | |
| 19 | 12 | |
| 20 | 29 |
About Dana Haddad
Dana Haddad is a scholar working on Biotechnology, Genetics and Oncology, having authored 29 papers that have together received 488 indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), Cancer Research and Treatments (11 papers) and CAR-T cell therapy research (11 papers). The work is most often cited by research in Biotechnology (158 citations), Genetics (319 citations) and Oncology (217 citations). Dana Haddad has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Yuman Fong, Aladar A. Szalay, Joshua Carson, Nanhai G. Chen, Joyce T. Au, Pat Zanzonico, Qian Zhang, Chun‐Hao Chen, Sepideh Gholami and Arjun Mittra. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.